CBOE · Cboe Global Markets, Inc.
Price & Indicators
Up next
AI Brief
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders NeutralIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted Diluted EPS non-GAAP | $3.56 | 2Q26 | — |
|
|
|||
| Adjusted operating expenses non-GAAP | $216.7M | 2Q26 | — |
|
|
|||
GAAP → non-GAAP reconciliationGAAP Operating expenses $255.6M
-$38.9M Operating non-GAAP adjustments noted above
= Adjusted operating expenses $216.7M
|
|||
| EBITDA non-GAAP | $516.5M | 2Q26 | — |
|
|
|||
GAAP → non-GAAP reconciliationGAAP Net income allocated to common stockholders $351.8M
-$5M Interest (income) expense, net
+$141.6M Income tax provision
+$28.1M Depreciation and amortization
= EBITDA $516.5M
|
|||
| EBITDA Margin % non-GAAP | 70.6% | 2Q26 | — |
|
|
|||
| Europe and Asia Pacific net revenue | $84.8M | 2Q26 | — |
|
|
|||
| Futures net revenue | $30.6M | 2Q26 | — |
|
|
|||
| Global FX net revenue | $27.6M | 2Q26 | — |
|
|
|||
| Index options ADV | 6.21M | 2Q 2026 | — |
|
|
|||
| Multi-listed options ADV | 15.65M | 2Q 2026 | — |
|
|
|||
| Multi-listed options market share | 23.5% | 2Q 2026 | — |
|
|
|||
| North American Equities net revenue | $114.7M | 2Q26 | — |
|
|
|||
| Operating EBITDA non-GAAP | $504.1M | 2Q26 | — |
|
|
|||
GAAP → non-GAAP reconciliationGAAP Operating income $476M
+$28.1M Depreciation and amortization
= Operating EBITDA $504.1M
|
|||
| Operating EBITDA Margin % non-GAAP | 68.9% | 2Q26 | — |
|
|
|||
| Options net revenue | $473.9M | 2Q26 | — |
|
|
|||
| Total Company Options ADV | 21.86M | 2Q 2026 | — |
|
|
|||
| Total industry ADV | 72.84M | 2Q 2026 | — |
|
|
|||
| Adjusted Net Income Allocated to Common Stockholders Margin % non-GAAP | 53.3% | Q1 2026 | — |
| Adjusted Operating Margin % non-GAAP | 72.4% | Q1 2026 | — |
| Options total market share | 29.1% | first quarter 2026 | — |
| Net Income Allocated to Common Stockholders Margin % non-GAAP | 47.8% | 4Q25 Adjusted | — |
| Operating Income non-GAAP | $450.5M | 4Q25 Adjusted | — |
| Operating Margin % non-GAAP | 67.1% | 4Q25 Adjusted | — |
| Total Operating Expenses non-GAAP | $220.6M | 4Q25 Adjusted | — |
| Total Options market share | 29.2% | 4Q 2025 | — |
| Total Options RPC | $0.32 | 4Q 2025 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Financial Data & Stock Exchanges — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
CBOE
this stock
Cboe Global Markets, Inc.
|
$30.93B | +18.0% | +217.0% | 23.1 | 3.1% |
|
SPGI
S&P Global Inc.
|
$121.39B | — | +7.1% | 27.4 | 3.0% |
|
CME
Cme Group Inc.
|
$97.01B | -1.2% | +6.4% | 22.9 | 1.7% |
|
ICE
Intercontinental Exchange, Inc.
|
$86.86B | -4.5% | -2.1% | 21.9 | 1.4% |
|
MCO
Moodys Corp /De/
|
$82.76B | -5.1% | +16.6% | 30.3 | 1.8% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| CBOE | +3.3% | +8.3% | +2.1% | -4.5% | +18.0% |
| SPY | +0.4% | +4.5% | +13.8% | +3.9% | +13.9% |
| vs SPY | +2.9% | +3.9% | -11.7% | -8.5% | +4.1% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.